Velban and Reglan drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Velban (vinblastine sulfate) and Reglan (metoclopramide hydrochloride). Common drug interactions include mental impairment among females and acute circulatory failure among males.

The phase IV clinical study analyzes what interactions people have when they take Velban and Reglan. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Velban?

Velban has active ingredients of vinblastine sulfate. eHealthMe is studying from 191 Velban users. Check the latest studies of Velban.

What is Reglan?

Reglan has active ingredients of metoclopramide hydrochloride. It is often used in gastroparesis. eHealthMe is studying from 29,455 Reglan users. Check the latest studies of Reglan.

On Jul, 31, 2026

11 people who take Velban and Reglan together, and have interactions are studied.

What are the common drug interactions of Velban and Reglan, by gender? *:

female:

Mental impairment (a condition affecting the body, perhaps through sight or hearing loss, a mobility difficulty or a health condition)
Skin papilloma (a general medical term for a tumour of the skin or mucous membrane with finger-like projections)
Abdominal discomfort
Asthenia (weakness)
Breast cancer metastatic
Diarrhoea
Ecchymosis (a discoloration of the skin resulting from bleeding underneath)
Dyspnoea (difficult or laboured respiration)
Constipation
Death

male:

Acute circulatory failure (shock)
Colitis (inflammation of colon)
Vomiting
Cytomegalovirus infection
Cytomegalovirus retinitis (retina infection with cytomegalo virus)
Dehydration (dryness resulting from the removal of water)
Diarrhoea
Dyspnoea (difficult or laboured respiration)
Gastroenteritis (inflammation of stomach and intestine)
Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)

What are the common drug interactions of Velban and Reglan, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Acute circulatory failure (shock)
Colitis (inflammation of colon)
Cytomegalovirus infection
Cytomegalovirus retinitis (retina infection with cytomegalo virus)
Dehydration (dryness resulting from the removal of water)
Diarrhoea
Dyspnoea (difficult or laboured respiration)
Gastroenteritis (inflammation of stomach and intestine)
Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
Oesophagitis (inflammation of oesophagus)

40-49:

n/a

50-59:

Temperature intolerance (inability to go in temperature)
Thrombocytopenia (decrease of platelets in blood)
Upper respiratory tract infection
Varicella
Vomiting
White blood cell count decreased
Abdominal pain
Acetabulum fracture (socket of the hip joint- fracture)
Actinic keratosis (skin disease due to sun exposure)
Anaemia (lack of blood)

60+:

Activated partial thromboplastin time prolonged
Dyspnoea (difficult or laboured respiration)
Abdominal pain
Abdominal tenderness
Blood in stool
Fatigue (feeling of tiredness)
Haematocrit decreased
Haemoglobin decreased
Hepatic function abnormal
Jaundice (a yellowish pigmentation of the skin, the conjunctival membranes)

What are the existing conditions these people have? *

Breast Cancer: 5 people, 45.45%
Breast Cancer Metastatic: 4 people, 36.36%
Venous Thrombosis (blood clot (thrombus) that forms within a vein): 2 people, 18.18%
Colon Cancer Metastatic (cancer of colon spreads to other part of body): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Velban and Reglan?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously